FDA Inspection 1050332 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on Apr 25, 2018 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Salt Lake City, UT (United States)